Literature DB >> 17461475

Diagnostic criteria for acute liver failure due to Wilson disease.

Christoph Eisenbach1, Olivia Sieg, Wolfgang Stremmel, Jens Encke, Uta Merle.   

Abstract

AIM: To describe the diagnostic criteria for acute liver failure due to Wilson disease (WD), which is an uncommon cause of acute liver failure (ALF).
METHODS: We compared findings of patients presenting with ALF due to WD to those with ALF of other etiologies.
RESULTS: Previously described criteria, such as low alkaline phosphatase activity, ratio of low alkaline phosphatase to total bilirubin or ratio of high aspartate aminotransferase (AST) to alanine aminotransferase (ALT), failed to identify patients with ALF due to WD. There were significant differences in low ALT and AST activities (53 +/- 43 vs 1982 +/- 938, P < 0.0001 and 87 +/- 44 vs 2756 +/- 2941, P = 0.037, respectively), low choline esterase activity (1.79 +/- 1.2 vs 4.30 +/- 1.2, P = 0.009), high urine copper concentrations (93.4 +/- 144.0 vs 3.5 +/- 1.8, P = 0.001) and low hemoglobin (7.0 +/- 2.2 vs 12.6 +/- 1.8, P < 0.0001) in patients with ALF caused by WD as compared with other etiologies. Interestingly, 4 of 7 patients with ALF due to WD survived without liver transplantation.
CONCLUSION: In ALF, these criteria can help establish a diagnosis of WD. Where applicable, slit-lamp examination for presence of Kayser-Fleischer rings and liver biopsy for determination of hepatic copper concentration still remain important for the diagnosis of ALF due to WD. The need for liver transplantation should be evaluated carefully as the prognosis is not necessarily fatal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17461475      PMCID: PMC4146951          DOI: 10.3748/wjg.v13.i11.1711

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Wilson disease.

Authors:  Jonathan D Gitlin
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

2.  Low serum alkaline phosphatase activity in Wilson's disease.

Authors:  W A Shaver; H Bhatt; B Combes
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

3.  Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.

Authors:  P Hillenbrand; S P Parbhoo; A Jedrychowski; S Sherlock
Journal:  Scand J Gastroenterol Suppl       Date:  1973

Review 4.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

5.  Wilson's disease: indications for liver transplants.

Authors:  I Sternlieb
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

6.  Diagnosis of Wilson's disease presenting as fulminant hepatic failure.

Authors:  A J McCullough; C R Fleming; J L Thistle; W P Baldus; J Ludwig; J T McCall; E R Dickson
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

7.  Wilson's disease.

Authors:  I H Scheinberg
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb

8.  Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.

Authors:  H L Tillmann; J Hadem; L Leifeld; K Zachou; A Canbay; C Eisenbach; I Graziadei; J Encke; H Schmidt; W Vogel; A Schneider; U Spengler; G Gerken; G N Dalekos; H Wedemeyer; M P Manns
Journal:  J Viral Hepat       Date:  2006-04       Impact factor: 3.728

9.  Orthotopic liver transplantation for Wilson's disease: a single-center experience.

Authors:  S Emre; E O Atillasoy; S Ozdemir; M Schilsky; C V Rathna Varma; S N Thung; I Sternlieb; S R Guy; P A Sheiner; M E Schwartz; C M Miller
Journal:  Transplantation       Date:  2001-10-15       Impact factor: 4.939

Review 10.  Diagnosis and phenotypic classification of Wilson disease.

Authors:  Peter Ferenci; Karel Caca; Georgios Loudianos; Georgina Mieli-Vergani; Stuart Tanner; Irmin Sternlieb; Michael Schilsky; Diane Cox; Frieder Berr
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

View more
  18 in total

1.  Report of the ASFA apheresis registry study on Wilson's disease.

Authors:  Huy P Pham; Joseph Schwartz; Laura Cooling; Jan C Hofmann; Haewon C Kim; Shanna Morgan; Monica B Pagano; Jennifer Schneiderman; Jeffrey L Winters; Chisa Yamada; Edward C C Wong; Yanyun Wu
Journal:  J Clin Apher       Date:  2015-08-14       Impact factor: 2.821

2.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

Review 3.  Wilson's disease: update on integrated Chinese and Western medicine.

Authors:  Wen-Jie Li; Jun-Feng Wang; Xiao-Ping Wang
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

4.  A review on laboratory liver function tests.

Authors:  Shivaraj Gowda; Prakash B Desai; Vinayak V Hull; Avinash A K Math; Sonal N Vernekar; Shruthi S Kulkarni
Journal:  Pan Afr Med J       Date:  2009-11-22

Review 5.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 6.  Clinical features of Wilson disease.

Authors:  Wolfgang Stremmel; Uta Merle; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2019-04

7.  Diagnosis and management of fulminant Wilson's disease: a single center's experience.

Authors:  Yi Tian; Guo-Zhong Gong; Xu Yang; Feng Peng
Journal:  World J Pediatr       Date:  2015-06-04       Impact factor: 2.764

Review 8.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

9.  Protective effects of Moringa oleifera Lam. leaves against arsenic-induced toxicity in mice.

Authors:  Afzal Sheikh; Fouzia Yeasmin; Smita Agarwal; Mashiur Rahman; Khairul Islam; Ekhtear Hossain; Shakhawoat Hossain; Md Rezaul Karim; Farjana Nikkon; Zahangir Alam Saud; Khaled Hossain
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

10.  Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh.

Authors:  Nurshad Ali; Md Ashraful Hoque; Abedul Haque; Kazi Abdus Salam; Md Rezaul Karim; Aminur Rahman; Khairul Islam; Zahangir Alam Saud; Md Abdul Khalek; Anwarul Azim Akhand; Mostaque Hossain; Abul Mandal; Md Rezaul Karim; Hideki Miyataka; Seiichiro Himeno; Khaled Hossain
Journal:  Environ Health       Date:  2010-07-10       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.